(Q37361492)

19 August 2017

Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

J P Sabo

1

1 reference

19 August 2017

M J Lamson

2

1 reference

19 August 2017

G Leitz

3

1 reference

19 August 2017

C L Yong

4

1 reference

19 August 2017

T R MacGregor

5

1 reference

19 August 2017

language of work or name

1 reference

1 January 2000

1 reference

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

1

1 reference

19 August 2017

E1

1 reference

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Drug interactions in patients infected with human immunodeficiency virus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Clinical pharmacokinetics of lamivudine

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2750996

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

2 September 2018

1 reference

12 December 2020

HPLC-UV method for the quantitation of nevirapine in biological matrices following solid phase extraction

1 reference

12 December 2020

Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party

1 reference

12 December 2020

Renal disposition and drug interaction screening of (-)-2'-deoxy-3'-thiacytidine (3TC) in the isolated perfused rat kidney

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Identifiers

DOI

10.1208/PS020101

1 reference

release_t5ju3onuobeo3kkuylm7odu3k4

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t5ju3onuobeo3kkuylm7odu3k4

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

1 reference